Doyle Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.23M Sell
9,869
-23,030
-70% -$5.58M 0.19% 78
2022
Q2
$8M Buy
32,899
+684
+2% +$168K 0.65% 55
2022
Q1
$7.79M Sell
32,215
-801
-2% -$184K 0.56% 58
2021
Q4
$7.43M Sell
33,016
-10,441
-24% -$2.2M 0.53% 60
2021
Q3
$9.24M Buy
43,457
+553
+1% +$127K 0.73% 53
2021
Q2
$10.5M Buy
42,904
+1,670
+4% +$411K 0.87% 45
2021
Q1
$10.3M Buy
41,234
+951
+2% +$227K 0.98% 40
2020
Q4
$9.26M Buy
40,283
+9,180
+30% +$2.12M 0.94% 39
2020
Q3
$7.91M Buy
31,103
+28,626
+1,156% +$7.09M 0.92% 39
2020
Q2
$584K Sell
2,477
-375
-13% -$85.6K 0.08% 107
2020
Q1
$578K Sell
2,852
-2
-0.1% -$437 0.09% 93
2019
Q4
$688K Buy
2,854
+262
+10% +$57.8K 0.09% 101
2019
Q3
$502K Sell
2,592
-419
-14% -$80.4K 0.07% 119
2019
Q2
$555K Buy
3,011
+3
+0.1% +$537 0.08% 106
2019
Q1
$517K Buy
3,008
+146
+5% +$27.9K 0.08% 108
2018
Q4
$557K Buy
2,862
+708
+33% +$138K 0.09% 93
2018
Q3
$447K Sell
2,154
-61
-3% -$12K 0.07% 117
2018
Q2
$409K Sell
2,215
-179
-7% -$31.7K 0.07% 122
2018
Q1
$408K Sell
2,394
-492
-17% -$90.3K 0.07% 113
2017
Q4
$502K Buy
2,886
+107
+4% +$18.9K 0.08% 98
2017
Q3
$518K Sell
2,779
-129
-4% -$22.9K 0.09% 91
2017
Q2
$501K Sell
2,908
-633
-18% -$103K 0.09% 88
2017
Q1
$581K Buy
+3,541
New +$588K 0.12% 77

Other funds holding AMGN

Doyle Wealth Management's AMGN Position: Q3 2022 in Review

Doyle Wealth Management reduced its Amgen (AMGN) stake by 70% in Q3 2022, selling an estimated $5.58M and leaving 9,869 shares worth $2.23M. The position accounts for 0.19% of the portfolio, ranked #78.

Doyle Wealth Management first reported a position in AMGN in Q1 2017 and has held it in 23 quarters since. The position peaked at $10.5M in Q2 2021. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

  • Doyle Wealth Management held 9,869 shares of Amgen worth $2.23M as of Q3 2022.
  • Doyle Wealth Management sold 23,030 Amgen shares in Q3 2022, an estimated $5.58M.
  • Amgen made up 0.19% of Doyle Wealth Management's portfolio in Q3 2022, its #78 holding.
  • Doyle Wealth Management first reported a position in Amgen in Q1 2017 and has held it in 23 quarters since.
  • Doyle Wealth Management's Amgen position peaked at $10.5M in Q2 2021.
  • 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Doyle Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.